Unraveling the obesity paradox in small cell lung cancer immunotherapy: unveiling prognostic insights through body composition analysis
No clear association between BMI and SCLC immunotherapy prognosis was observed. However, high adiposity exacerbated the adverse effects of sarcopenia in SCLC immunotherapy, and BSI demonstrated potential as a straightforward prognostic measure.
Authors
- Junhong Zhang (ORCID: https://orcid.org/0000-0003-0611-9478)
- Ruoxin Fang (ORCID: https://orcid.org/0000-0001-5395-3583)
- Tian Gan (ORCID: https://orcid.org/0000-0002-7833-7231)
- Jun Gong (ORCID: https://orcid.org/0000-0001-9744-7201)
- Ling Yan (ORCID: https://orcid.org/0000-0003-0533-3173)
- Yuchen Xu
- Conghua Xie (ORCID: https://orcid.org/0000-0003-1741-9628)
- Sha Xu (ORCID: https://orcid.org/0009-0008-8262-0233)
- Zhengkai Liao
Institutions
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-26
- DOI
- https://doi.org/10.3389/fimmu.2024.1439877
- Citations
- 3
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.85